Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response.
Formentini L, Sánchez-Aragó M, Sánchez-Cenizo L, Cuezva JM. Formentini L, et al. Among authors: sanchez cenizo l. Mol Cell. 2012 Mar 30;45(6):731-42. doi: 10.1016/j.molcel.2012.01.008. Epub 2012 Feb 16. Mol Cell. 2012. PMID: 22342343 Free article.
Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state.
Santacatterina F, Sánchez-Cenizo L, Formentini L, Mobasher MA, Casas E, Rueda CB, Martínez-Reyes I, Núñez de Arenas C, García-Bermúdez J, Zapata JM, Sánchez-Aragó M, Satrústegui J, Valverde ÁM, Cuezva JM. Santacatterina F, et al. Among authors: sanchez cenizo l. Oncotarget. 2016 Jan 5;7(1):490-508. doi: 10.18632/oncotarget.6357. Oncotarget. 2016. PMID: 26595676 Free PMC article.
In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.
Formentini L, Pereira MP, Sánchez-Cenizo L, Santacatterina F, Lucas JJ, Navarro C, Martínez-Serrano A, Cuezva JM. Formentini L, et al. Among authors: sanchez cenizo l. EMBO J. 2014 Apr 1;33(7):762-78. doi: 10.1002/embj.201386392. Epub 2014 Feb 12. EMBO J. 2014. PMID: 24521670 Free PMC article.
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.
Sánchez-Cenizo L, Formentini L, Aldea M, Ortega AD, García-Huerta P, Sánchez-Aragó M, Cuezva JM. Sánchez-Cenizo L, et al. J Biol Chem. 2010 Aug 13;285(33):25308-13. doi: 10.1074/jbc.M110.146480. Epub 2010 Jun 9. J Biol Chem. 2010. PMID: 20538613 Free PMC article.
Glucose avidity of carcinomas.
Ortega AD, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, Cuezva JM. Ortega AD, et al. Cancer Lett. 2009 Apr 18;276(2):125-35. doi: 10.1016/j.canlet.2008.08.007. Epub 2008 Sep 14. Cancer Lett. 2009. PMID: 18790562 Review.
The tumor suppressor function of mitochondria: translation into the clinics.
Cuezva JM, Ortega AD, Willers I, Sánchez-Cenizo L, Aldea M, Sánchez-Aragó M. Cuezva JM, et al. Among authors: sanchez cenizo l. Biochim Biophys Acta. 2009 Dec;1792(12):1145-58. doi: 10.1016/j.bbadis.2009.01.006. Epub 2009 Jan 23. Biochim Biophys Acta. 2009. PMID: 19419707 Free article. Review.
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.
Sánchez-Aragó M, Formentini L, Martínez-Reyes I, García-Bermudez J, Santacatterina F, Sánchez-Cenizo L, Willers IM, Aldea M, Nájera L, Juarránz A, López EC, Clofent J, Navarro C, Espinosa E, Cuezva JM. Sánchez-Aragó M, et al. Among authors: sanchez cenizo l. Oncogenesis. 2013 Apr 22;2(4):e46. doi: 10.1038/oncsis.2013.9. Oncogenesis. 2013. PMID: 23608753 Free PMC article.
Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study.
Labarta JI, de Arriba A, Ferrer M, Loranca M, Martos JM, Rodríguez A, Samaniego ML, Sánchez-Cenizo L. Labarta JI, et al. Among authors: sanchez cenizo l. J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):923-932. doi: 10.1515/jpem-2019-0438. J Pediatr Endocrinol Metab. 2020. PMID: 32623373
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain.
Sánchez-Cenizo L, Aller J, Martínez-Sesmero JM, Mir N, Peral C, Rubio-Rodríguez D, Rubio-Terrés C. Sánchez-Cenizo L, et al. Clinicoecon Outcomes Res. 2019 Jul 22;11:465-475. doi: 10.2147/CEOR.S204276. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31413609 Free PMC article.
Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain.
Peral C, Cordido F, Gimeno-Ballester V, Mir N, Sánchez-Cenizo L, Rubio-Rodríguez D, Rubio-Terrés C. Peral C, et al. Among authors: sanchez cenizo l. Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):105-114. doi: 10.1080/14737167.2019.1610396. Epub 2019 May 6. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31055976
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page